相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group
Sanne Nieuwenhuizen et al.
CANCERS (2020)
Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses
Jack R. Andrews et al.
EUROPEAN UROLOGY (2019)
Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis
Martijn R. Meijerink et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma: Systematic Review of Randomized Controlled Trials with Meta-Analysis and Trial Sequential Analysis
Xiao-Lin Xu et al.
RADIOLOGY (2018)
Ablation versus Resection for Stage 1A Renal Cell Carcinoma: National Variation in Clinical Management and Selected Outcomes
Johannes Uhlig et al.
RADIOLOGY (2018)
Survival Rates after Thermal Ablation versus Stereotactic Radiation Therapy for Stage 1 Non-Small Cell Lung Cancer: A National Cancer Database Study
Johannes Uhlig et al.
RADIOLOGY (2018)
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
Theo Ruers et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
Theo Ruers et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Cirse Quality Assurance Document and Standards for Classification of Complications: The Cirse Classification System
D. K. Filippiadis et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2017)
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN projectaEuro
A. Kramar et al.
ANNALS OF ONCOLOGY (2015)
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) (vol 26, pg 873, 2015)
S. Gourgou-Bourgade et al.
ANNALS OF ONCOLOGY (2015)
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
C. A. Bellera et al.
ANNALS OF ONCOLOGY (2015)
Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)
Franck Bonnetain et al.
EUROPEAN JOURNAL OF CANCER (2014)
Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria-A 10-Year Update
Muneeb Ahmed et al.
RADIOLOGY (2014)
Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: Formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trials
Carine A. Bellera et al.
EUROPEAN JOURNAL OF CANCER (2013)
A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma
Kai Feng et al.
JOURNAL OF HEPATOLOGY (2012)
Quality Improvement Guidelines for Radiofrequency Ablation of Liver Tumours
Laura Crocetti et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
The Clavien-Dindo Classification of Surgical Complications Five-Year Experience
Pierre A. Clavien et al.
ANNALS OF SURGERY (2009)
Society of Interventional Radiology Position Statement on Percutaneous Radiofrequency Ablation for the Treatment of Liver Tumors (Reprinted from J Vasc Interv Radiol vol 20, pg 3-8, 2009)
Debra A. Gervais et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2009)
分享论文
